About this book:

Pharma Production Playbook: GMP, Facility Design, and Regulatory Compliance serves as a comprehensive guide for pharmaceutical and biologics manufacturing professionals, translating regulatory expectations into actionable practices that ensure product quality and patient safety. It establishes the foundational link between Good Manufacturing Practices (GMP), facility design principles, and operational behaviors, emphasizing that true compliance arises from embedding quality into every aspect of manufacturing—from raw material sourcing to final product distribution—rather than treating it as a mere inspection exercise. The book underscores that a strong quality culture, driven by leadership commitment and employee empowerment, is essential for sustaining GMP requirements and driving continuous improvement.

The text systematically navigates the global regulatory landscape, detailing the roles and expectations of the FDA, EMA, ICH, and PIC/S, and explains how their guidelines harmonize to create a unified framework for international market access. It then delves into the core components of a robust Quality Management System (QMS), including document control, standard operating procedures (SOPs), batch records, and data integrity (ALCOA+ principles), while providing practical tools for Quality Risk Management (ICH Q9) such as FMEA and HACCP. Significant attention is given to facility design and hygienic principles, covering cleanroom classification, pressure cascades, HVAC design, critical utilities (PW, WFI, clean steam, gases), and equipment qualification (DQ/IQ/OQ/PQ), all framed within a risk-based approach to ensure resources are focused on areas impacting product quality and patient safety.

Further chapters address specialized manufacturing considerations, including aseptic processing and sterile fill-finish (aligned with EU Annex 1 and FDA guidance), contamination control strategy (CCS) supported by environmental monitoring, microbiology methods (conventional and rapid), and the unique implications of biologics manufacturing—such as single-use systems, upstream/downstream processing challenges, and validation strategies for complex molecules. The book concludes by linking operational excellence to post-market activities, detailing deviation investigations, root cause analysis, CAPA, change control, annual product reviews (APR/PQR), internal audit programs, inspection readiness, serialization, traceability, complaint handling, and recall execution, thereby creating a closed-loop system that connects manufacturing performance to patient outcomes through rigorous quality assurance throughout the product lifecycle.

What You'll Find Inside:

• Foundations of GMP and quality culture, covering the 5 P's (People, Products, Processes, Procedures, Premises) and the evolution of quality systems from reactive control to proactive quality assurance.
• Global regulatory landscape overview: FDA, EMA, ICH guidelines, and PIC/S harmonization, with practical guidance on meeting regional requirements for market access.
• Quality Management Systems, document control, SOPs, batch records, and electronic batch records (EBRs), emphasizing data integrity principles (ALCOA+) for traceable and compliant documentation.
• Facility design and environmental controls: cleanroom classification, zoning, pressure cascades, HVAC design, critical utilities (PW, WFI, clean steam, gases), and equipment qualification lifecycle (DQ/IQ/OQ/PQ) to support contamination control.
• Specialized biologics manufacturing topics: single-use systems, upstream/downstream considerations, aseptic processing, contamination control strategy, and lifecycle management tools (change control, APR/PQR, CAPA) for sustained compliance and continuous improvement.

Who's It For:

This book is intended for pharmaceutical and biologics manufacturing professionals, including process engineers, quality assurance and validation specialists, facility designers, and regulatory affairs personnel. It is especially valuable for those involved in establishing or maintaining GMP‑compliant operations, scaling up processes for commercial launch, or strengthening legacy facilities. Readers seeking practical guidance on facility design, utilities, equipment qualification, process validation, and contamination control will find actionable frameworks and checklists. The content also supports training programs and continuous improvement initiatives across manufacturing sites.